Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Formerly part of GE Healthcare Life Sciences and now part of Danaher's Life Sciences Group, we have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020. Cytiva is now a 3.3 billion USD global life sciences leader with over 7000 associates across 40 sites who are dedicated to our vision to improve access to life-changing therapies that transform human health. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.
Biotechnology, Contract Research & Scientific Services, Scientific Supplies
- Contract Manufacturing
- Drug Discovery
- Gene Therapy
- High-throughput Screening
- Immune Therapy
- Molecular Diagnostics
- Product Development
- Teaching and Training
Contract Research & Scientific Services , Scientific Supplies
Preclinical and clinical biologics CDMO services up to phase II Our Fast Trak group offers products, services and training in one place so you can avoid the pitfalls of working with multiple suppliers; inefficient processes, delayed batches, lack of product and process expertise. Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency. Beyond that, you will have the tools and know-how you need to take your process forward independently.
We are looking For:
Looking to support emerging biotechnology companies on their journey from disease research and drug discovery to clinical and commercial manufacturing of biologics.